SSRIs and Cosmetic Surgery: Continue or Stop Antidepressants Before Korean Procedures?

Patients on SSRIs (selective serotonin reuptake inhibitors) frequently ask whether to stop their antidepressant before cosmetic surgery. The clinical evidence is nuanced — there are theoretical bleeding and drug-interaction concerns, but routine discontinuation isn\'t generally recommended. Mental-health stability matters as much as perioperative risk minimization. This FAQ explains the current thinking.

Common SSRIs Korean cosmetic patients take

• Fluoxetine (Prozac).
• Sertraline (Zoloft).
• Paroxetine (Paxil).
• Escitalopram (Lexapro / Cipralex).
• Citalopram (Celexa).
• Fluvoxamine (Luvox).
• Other related SNRIs (venlafaxine, duloxetine).

The theoretical concerns

Bleeding risk

• SSRIs reduce platelet serotonin uptake.
• Theoretical increased bleeding risk.
• Particularly fluoxetine and fluvoxamine.
• Risk magnified with NSAIDs or anticoagulants.
• Clinical evidence in cosmetic surgery: inconsistent.

Drug interactions

• CYP450 enzyme inhibition affects metabolism of:
• Benzodiazepines (potentially prolonged sedation).
• Tramadol, codeine, oxycodone (reduced analgesic effect).
• Other anesthetic agents.
• Anesthesia teams account for these.

Serotonin syndrome

• Risk with concurrent fentanyl, tramadol, methadone.
• Anesthesia teams aware and select alternative agents.
• Rare but serious if it occurs.

The clinical evidence

What studies show

• Studies on antidepressants and surgical bleeding inconsistent.
• Some increased bleeding rates; others no difference.
• Cosmetic surgery specifically: ~2,500-patient studies show variable results.
• Effect sizes generally modest.
• Clinical relevance often limited.

What major plastic surgery societies recommend

• American Society of Plastic Surgeons: don\'t routinely discontinue.
• Discontinuation risk often exceeds bleeding risk.
• Coordinate with prescribing physician for individual cases.
• Korean clinical practice generally aligned.

Why discontinuation is risky

Discontinuation syndrome

• Sudden SSRI cessation can produce:
• Mood worsening.
• Anxiety spike.
• Brain fog and dizziness.
• Flu-like symptoms.
• Sleep disruption.
• Sometimes rebound suicidal thoughts.

Worst time for mental destabilization

• Surgery itself is stressful.
• Recovery often emotionally challenging.
• Body image changes can trigger distress.
• Mental stability supports good recovery.
• Discontinuation can produce all this without surgery benefit.

Korean clinical approach

Standard practice

• Disclose SSRI use at consultation.
• Confirm with anesthesia team.
• Generally continue medication through surgery.
• Anesthesia adjustments made based on medication.
• Avoid serotonin-syndrome-risk drug combinations.

Special situations

• Major surgery with high bleeding risk: discuss with prescriber.
• Some surgeons recommend hold for major procedures.
• Decision case-by-case based on disease stability and procedure type.
• Never discontinue without prescriber input.

Common patient questions

Will my SSRI cause excessive bleeding?

Possibly modest increase, but rarely clinically significant. Most cosmetic procedures have acceptable hemostasis even on SSRIs. Surgeon will use careful technique regardless.

Should I stop my Lexapro before rhinoplasty?

Generally no — coordinate with prescribing doctor. Stopping risks discontinuation syndrome and depression worsening, often with no meaningful benefit to surgical outcome.

What about pain medications after surgery?

Tylenol generally fine. Tramadol use requires caution (serotonin syndrome risk). Discuss with anesthesia and surgeon. Acetaminophen plus NSAID with meal usually adequate for most cosmetic recovery.

Will SSRIs interact with anesthesia?

Anesthesia teams adjust agent selection. Inform anesthesiologist of all medications. Major interaction concerns avoided through careful drug selection.

What if I\'m on multiple psychiatric medications?

Coordinate carefully with prescribing psychiatrist. More complex regimens require more individualized planning. Don\'t make changes unilaterally.

How long after starting an SSRI should I wait for surgery?

Allow stabilization (typically 6–8 weeks on stable dose). Surgery during early SSRI initiation is suboptimal — both treatments need stable platforms.

For the prescribing physician

What to communicate to surgical team

• Specific medication and dose.
• Duration of treatment.
• Disease stability status.
• Recent changes or response.
• Other psychiatric medications.
• Recommendation regarding perioperative continuation.

What surgical team should know

• Recommended discontinuation rare.
• Coordinate with prescriber if hold considered.
• Anesthesia agent selection adjustments.
• Pain medication strategy avoiding serotonin syndrome risk.
• Mental health monitoring during recovery.

Specific medication considerations

Fluoxetine (Prozac)

• Long half-life.
• Effects persist weeks after last dose.
• "Discontinuation" doesn\'t fully eliminate effect.
• Continue through surgery typically.

Sertraline (Zoloft)

• Generally well-tolerated perioperatively.
• Standard recommendation: continue.
• Common in Korean clinical practice.

Escitalopram (Lexapro)

• Generally low concern.
• Continue through surgery.
• Among most commonly prescribed.

Venlafaxine (Effexor) — SNRI

• Particularly difficult discontinuation if stopped abruptly.
• Continue or very gradual taper if needed.
• Discontinuation syndrome significant.

Mental health and cosmetic surgery

The broader context

• Patients with treated depression have generally good cosmetic outcomes.
• Patients with untreated mental health conditions have worse satisfaction.
• SSRI-stable patients are not "more risky" patients.
• Don\'t feel stigmatized for psychiatric medication.
• Disclosure helps medical team optimize care.

Korean clinic perspective

• SSRI use increasingly common globally including Korea.
• Korean clinics serving foreign patients accustomed to medication management.
• Routine inquiry about psychiatric medications.
• Generally accommodating perioperative continuation.

Common mistakes to avoid

• Stopping SSRIs unilaterally without prescriber input.
• Not disclosing psychiatric medications to surgical team.
• Adding tramadol post-op without checking interaction.
• Stopping too soon before surgery (discontinuation syndrome occurs).
• Not planning resumption schedule.
• Self-discontinuing during recovery period.

The honest framing

SSRIs and cosmetic surgery generally coexist safely without medication discontinuation. The bleeding risk is real but usually modest; the discontinuation risk to mental health is often greater. The patients who manage this well coordinate with both prescribing doctor and surgical team, disclose all medications, continue treatment unless specifically advised otherwise, and prioritize mental stability through the recovery period. The patients who unilaterally stop SSRIs to "be safe" risk discontinuation syndrome, depression worsening, and difficult recovery — typically without meaningful surgical benefit. Trust the clinical evidence: continue your antidepressant treatment unless your prescribing doctor specifically advises otherwise.